Xilio Therapeutics
XLO
#9736
Rank
ยฃ27.67 M
Marketcap
ยฃ0.53
Share price
-4.24%
Change (1 day)
-48.29%
Change (1 year)

Revenue for Xilio Therapeutics (XLO)

Revenue in 2024 (TTM): ยฃ4.92 Million

According to Xilio Therapeutics's latest financial reports the company's current revenue (TTM ) is ยฃ4.84 Million. .The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Xilio Therapeutics from 2021 to 2024

Annual revenue

Year Revenue Change
2024 ยฃ5.05 M
2022 N/A
2021 N/A